Aude Gerspacher, a senior litigation analyst for Bloomberg Intelligence, and Michael Carrier, a professor at Rutgers University Law School, discuss why a federal judge ruled that Allergan’s bid to use an Indian tribe to protect one of its drug patents is illegal. They speak with Bloomberg's June Grasso and Greg Stohr on Bloomberg Radio's Bloomberg Law.
See omnystudio.com/listener for privacy information.
